
Sign up to save your podcasts
Or


The SSRI escitalopram beat out a placebo in ameliorating the frequency and severity of hot flashes in menopausal women. Would cheaper SSRIs also do the trick? We talk with the first author of the JAMA paper.
Interview-related links:
By NEJM Group4.5
5656 ratings
The SSRI escitalopram beat out a placebo in ameliorating the frequency and severity of hot flashes in menopausal women. Would cheaper SSRIs also do the trick? We talk with the first author of the JAMA paper.
Interview-related links:

7,874 Listeners

320 Listeners

2,050 Listeners

124 Listeners

501 Listeners

298 Listeners

904 Listeners

266 Listeners

3,387 Listeners

113,494 Listeners

89 Listeners

5 Listeners

90 Listeners

520 Listeners

2,582 Listeners

367 Listeners

16,556 Listeners

58 Listeners

31 Listeners

66 Listeners